Abstract: Provided herein are methods of preparing cell-free DNA (cfDNA) for sequencing such that variant allele frequencies are maintained. Also provided are sequencing libraries prepared according to such methods. In addition, methods are provided for analyzing sequencing reads to determine variant allele frequencies. These methods may be used for diagnosing and/or evaluating cancer patients.

Abstract: The invention relates to compounds of Formula (I), salts thereof, combinations, pharmaceutical compositions thereof, as well as therapeutic methods of treatment and prevention.

Abstract: This invention relates to polynucleotides comprising optimized aspartylglucosaminidase (AGA) open reading frames and vectors and cells comprising the same. The invention further relates to methods of using the same for delivery of the open reading frame to a cell or a subject and methods for treating aspartylglucosaminuria (AGU) in a subject.

Abstract: The invention relates to chimeric AAV capsids targeted to the central nervous system, virus vectors comprising the same, and methods of using the vectors to target the central nervous system. The invention further relates to chimeric AAV capsids targeted to oligodendrocytes, virus vectors comprising the same, and methods of using the vectors to target oligodendrocytes.

Abstract: This invention relates to SARS-CoV-2 viruses adapted with nanoluciferase reporter molecules and mouse-adapted SARS-CoV-2 viruses, compositions including the same and methods of use thereof.

Abstract: Provided are antibodies, and antigen-binding fragments thereof, which specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage gated calcium channel, and related compositions, kits, and methods of use thereof, for instance, administration to a subject in need thereof to modify an immune response, for example, in the treatment of cancer.

Abstract: Nanoparticles coated with extracellular matrix (ECM) are provided, in some aspects, for the delivery of a therapeutic protein, nucleic acid, or drug. In some embodiments, the nanoparticles are delivered to a subject via inhalation or aerosol delivery. Also provided, in some aspects, are methods for treating acute lung injury comprising administering ?-Klotho (?Klotho) protein or DNA to a subject.

Abstract: The present invention relates to a bio-based polyol comprising a thiol-epoxy reaction product of an epoxidized nut or seed oil derivative, and a thiol-containing reactant. The bio-based polyol of the present invention can then be combined with a diisocyanate or a polymeric isocyanate to create a polyurethane material.

Abstract: Compositions and methods of transplanting cells by grafting strategies into solid organs (especially internal organs) are provided. These methods and compositions can be used to repair diseased organs or to establish models of disease states in experimental hosts. The method involves attachment onto the surface of a tissue or organ, a patch graft, a “bandaid-like” covering, containing epithelial cells with supporting early lineage stage mesenchymal cells. The cells are incorporated into soft gel-forming biomaterials prepared under serum-free, defined conditions comprised of nutrients, lipids, vitamins, and regulatory signals that collectively support stemness of the donor cells. The graft is covered with a biodegradable, biocompatible, bioresorbable backing used to affix the graft to the target site. The cells in the graft migrate into and throughout the tissue such that within a couple of weeks they are uniformly dispersed within the recipient (host) tissue.

Abstract: A heliostat includes a reflecting surface; an elastically deformable frame on which the reflecting surface is mounted; a truss structure behind the elastically deformable frame that includes at least four bracing struts with first ends attached to the elastically deformable frame and second ends attached to at least one node located centrally behind the frame; at least one actuator connected to at least one of the at least four struts at the at least one node; an electronic control system configured to communicate with the least one actuator; and a dual-axis mount to support and orient the above assembly. The actuation of the at least one actuator in response to the electronic control system causes compression or tension of at least one of the at least four bracing struts to thereby control a shape of the reflecting surface and the elastically deformable frame in at least low order bending modes.

Abstract: A computer system for use in monitoring blood glucose level monitoring, the computer system configured, in response to receiving electrocardiogram data measured over a given period of time for a given subject, to classify the electrocardiogram data using at least one neural network and a personalised model which is specific to the given subject so as to identify whether a low blood glucose level condition is present wherein blood glucose level falls below a predefined level and, upon identifying the presence of the low blood glucose level condition, to flag an alarm condition.

Abstract: Provided is a learning method, a learning program, a learning device, and a learning system, for training a classification model, to further raise the correct answer rate of classification by the classification model. The learning method includes execution of generating one piece of composite data by compositing a plurality of pieces of training data of which classification has each been set, or a plurality of pieces of converted data obtained by converting the plurality of pieces of training data, at a predetermined ratio, inputting one or a plurality of pieces of the composite data into the classification model, and updating a parameter of the classification model so that classification of the plurality of pieces of training data included in the composite data is replicated at the predetermined ratio by output of the classification model, by a computer provided with at least one hardware processor and at least one memory.

Abstract: Phase-changing fuel compositions which can generate hydrogen are provided herein. The compositions can comprise a hydrogen carrier at least partially dissolved in a polar organic solvent. The hydrogen carrier includes ammonia borane and an alkylamine borane such as methylamine borane or methylenediamine bisborane. The hydrogen carrier act as the primary fuel source in the compositions and can be present in an amount of at least 60% by weight, based on the weight of the hydrogen generation composition. The hydrogen generation compositions are a liquid at temperatures of 5° C. or greater or 25° C. or greater. Methods for the production of hydrogen from the hydrogen generation compositions are further disclosed.

Abstract: The vibration-driven energy harvester includes: a first electrode; a second electrode facing the first electrode; a holder holding the first electrode and the second electrode so as to be movable relative to each other; a half-wave rectifier electrically connected to the first and the second electrodes that causes current flowing from the first electrode to the second electrode to flow to an output unit, and cuts off current flowing from the second electrode toward the first electrode; and a second rectifying element electrically connected to the first and the second electrodes that allows the current flowing from the second electrode to the first electrode and blocks the current flowing from the first electrode to the second electrode, wherein: the first electrode has a positively charged electret in a surface facing the second electrode, or the second electrode has a negatively charged electret in a surface facing the first electrode.

Abstract: The present invention relates to a resist composition, especially for use in the production of electronic components via electron beam lithography. In addition to the usual base polymeric component (resist polymer), a secondary electron generator is included in resist compositions of the invention in order to promote secondary electron generation. This unique combination of components increases the exposure sensitivity of resists in a controlled fashion which facilitates the effective production of high-resolution patterned substrates (and consequential electronic components), but at much higher write speeds.

Abstract: Monomers and copolymers are provided that both target antigen presenting cells (APCs) and activate toll-like receptor (TLR) on the APCs. In some embodiments, compositions and methods involve a polymer that targets the mannose receptor on APCs, in addition to activating a TLR. These can then be conjugated to protein antigens to efficiently target antigens to DCs and simultaneously induce the up-regulation of co-stimulatory molecules that are essential for effective T cell activation. This copolymer is a more efficient activator of DCs, as measured by the surface expression of co-stimulatory molecules and the release of proinflammatory cytokines, than the monomeric form the TLR agonist used in the polymer formulation. Aspects of the disclosure relate to novel compounds, methods, and compositions for treating diseases using the compounds, copolymers, and compositions described herein.

Abstract: The present invention relates to compositions and methods for the delivery of agents to a subject, particularly to the central nervous system (CNS).

Abstract: Compounds having a structure of formula (I), (I-A), (Ia)-(Ie), (A)-(E), and (II) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of disorders including prostate cancer are also provided.

Abstract: Disclosed herein are composite materials and methods of making and use thereof. The composite materials disclosed herein can comprise: a first metal oxide particle having a thermal stability and a specific reversible oxygen storage capacity, wherein the first metal oxide particle comprises a first metal oxide comprising a transition metal oxide; and a second metal oxide disposed on the first metal oxide particle; wherein the composite material has a thermal stability and a specific reversible oxygen storage capacity; and wherein the thermal stability of the composite material is greater than the thermal stability of the first metal oxide particle. The methods of use of the composite materials described herein can comprise using the composite material as a catalyst, as an oxygen carrier, as a catalyst support, in a fuel cell, in a catalytic converter, or a combination thereof.

Abstract: Certain embodiments are directed to novel heterotrimeric fusions in which the ectodomain of the TGF-? type II receptor (T?P?II) is coupled to the N- and C-terminal ends of the endoglin-domain of the TGF-? type III receptor (TpRIIIE). Certain embodiments are directed to novel heterotrimeric polypeptides in which the ectodomain of the TGF-? type II receptor (TI3RII) is coupled to the N- and C-terminal ends of the endoglin-domain (E domain) of the TGF-? type III receptor (TI3RIII). This trimeric receptor, known as RER, can bind all three TGF-? isoforms with sub-nanomolar affinity and is effective at neutralizing signaling induced by all three TGF-? isoforms, but not other ligands of the TGF-? superfamily, such as activins, growth and differentiation factors (GDFs), and bone morphonogenetic proteins (BMPs).